Comparison of Diameter and Perimeter Methods for Tumor Volume Calculation PURPOSE: Two identical, concurrent, parallel, multicenter, randomized, double-blind, double-dummy trials were conducted to ...

Background A 48-year-old man with a recent diagnosis of multiple myeloma and rapidly progressive oliguric end-stage renal disease requiring hemodialysis, presented with a serum calcium concentration ...

Pamidronate disodium 30mg, 90mg; per vial; pwd for IV infusion after reconstitution; contains mannitol. The principal pharmacologic action of pamidronate disodium is inhibition of bone resorption.

Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide. Patients with stage III myeloma and at least one lytic lesion received either ...

To the Editor: Arzoo et al. (July 19 issue) 1 report on a 23-year-old woman with Langerhans'-cell histiocytosis and severe pain due to osteolytic lesions, who had a good response to a 90-mg infusion ...

Learn everything you need to know about Pamidronate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

In this analysis, 3 bisphosphonates (alendronate, pamidronate, and zoledronic acid) and 1 RANK ligand inhibitor (denosumab) were evaluated for their effectiveness at preventing osteoclasts from ...

Treatment with a gonadotropin-releasing hormone agonist decreases bone mineral density and increases the risk of fracture in men with prostate cancer. We conducted a controlled study of the prevention ...

A 58-year-old, bisphosphonate-naive woman with a history of Hashimoto thyroiditis was admitted to hospital for hypercalcemia (2.81 [normal 2.20–2.60] mmol/L) due to primary hyperparathyroidism. She ...

June 21, 2002 -- Although there has been no effective therapy for osteogenesis imperfecta, a presentation June 20 at Endo 2002, the 84th annual meeting of The Endocrine Society, suggests that ...